Wellness influencers tout peptides for muscle and longevity, but experts quoted by Moneywise say not all of them have the science to back it up.
Recap by typeshit. Full story at Moneywise on MSN.
Reuters reports the trend among GLP-1 users is prompting calls for tighter rules on supplements sold alongside the drugs.
A pharmacist account flags two separate Class II recalls involving compounded tirzepatide. Tap through for which products are affected and why.
Health authorities in New South Wales issued a warning after a jump in hospitalisations linked to unapproved peptides sold as wellness products.
A University of Iowa chemist found no peptide in a Brooklyn corner-store vial, and another expert flagged at least 13 bacterial colonies that could cause infection.
An AI chatbot answer lays out single, dual and triple agonists, noting Lilly's retatrutide adds the glucagon receptor and is still investigational.
Nausea hit 20% of users vs 6% on placebo, with other gut effects near placebo levels. A GP tells Medical News Today phase 3 data is still needed.
Loading…